QuanMol, Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
QuanMol, Inc - overview
Established
2021
Location
Hillsborough, CA, US
Primary Industry
Healthcare IT
About
Based in California, US, and founded in 2021, QuanMol operates as a healthcare IT company which is a software & development platform that provides molecular-level solutions to product design. In February 2023, QuanMol, Inc raised USD 3 million in seed funding. QuanMol, Inc specializes in providing molecular design solutions through the use of AI-powered technology. The firm's molecular design is being advanced in industries such as medicine, materials, and energy.
The company developed QuanMol ReDefine which is a revolutionary in-silico discovery platform that employs a founding integration of physics-informed deep learning and computational chemistry methods. The company plans to use the January 2023 funds to improve the drug development process by providing AI-powered tools to medicinal chemists for data interpretation, reducing the cost and time associated with trial and error.
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.quanmol.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
QuanMol, Inc - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.